EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of Immunohistochemical Expression of Programmed Cell Death Ligand-1 in Invasive Urothelial Carcinoma

Aakanksha Rawat, Monika Gupta, Devendra Singh Pawar, Sunita Singh, Sujata Kumari

Annals of Pathology and Laboratory Medicine · 06.10.2024 · 11 (10) · A284-294

DOI: 10.21276/apalm.3398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pathology and Laboratory Medicine, online erschienen am 06.10.2024. Verfasst von Aakanksha Rawat und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infiltrating urothelial carcinoma is the most common histological variant (23.1%). This study was conducted to evaluate the immunohistochemical expression of PD-L1 in invasive urothelial carcinoma and to correlate PD-L1 expression with demographic data and the histological grade of urothelial carcinoma.

Methods

The study comprised a total of 65 cases of muscle-invasive urothelial carcinoma collected over a period of one year and evaluated for PD-L1 expression using the immunohistochemistry technique.

Results

Infiltrating urothelial carcinoma was the most common histological variant (23.1%), followed by poorly differentiated carcinoma (16.9%). PD-L1 positivity was observed in 47.7% of the total cases, while the remaining 52.3% showed no expression of PD-L1. Among the various histologic variants, poorly differentiated carcinoma (57.1%) was the largest group with weak expression of PD-L1; infiltrating urothelial carcinoma (26.7%) was the largest group with moderate expression of PD-L1, while the lymphoepithelioma-like variant (66.7%) was the largest group with strong expression of PD-L1. Our study was in concordance with other studies, showing that PD-L1 expression is not associated with clinicopathologic features like age, gender, and smoking status.

Conclusion

The present study shows a significant difference between the various groups in terms of the distribution of histologic variants and PD-L1 positivity according to the WHO classification (2016) as well as severity scoring by the IHC technique.

Zitieren

APA

Rawat, A., Gupta, M., Pawar, D. S., Singh, S., & Kumari, S. (2024). Assessment of Immunohistochemical Expression of Programmed Cell Death Ligand-1 in Invasive Urothelial Carcinoma. Annals of Pathology and Laboratory Medicine, 11(10), A284-294. https://doi.org/10.21276/apalm.3398

Vancouver

Rawat A, Gupta M, Pawar DS, Singh S, Kumari S. Assessment of Immunohistochemical Expression of Programmed Cell Death Ligand-1 in Invasive Urothelial Carcinoma. Annals of Pathology and Laboratory Medicine. 2024;11(10):A284-294. doi:10.21276/apalm.3398

BibTeX
@article{Rawat2024,
  author = {Rawat, Aakanksha and Gupta, Monika and Pawar, Devendra Singh and Singh, Sunita and Kumari, Sujata},
  title = {Assessment of Immunohistochemical Expression of Programmed Cell Death Ligand-1 in Invasive Urothelial Carcinoma},
  journal = {Annals of Pathology and Laboratory Medicine},
  year = {2024},
  volume = {11},
  number = {10},
  pages = {A284--294},
  doi = {10.21276/apalm.3398}
}
Kostenlos starten →